The International Journal of Tuberculosis and Lung Disease

Africa — not lost but still sick. Implementing interventions to prevent HIV-associated tuberculosis
pp. 1135-1136(2)
Author: Lawn, Stephen D.

Short-course Bangladesh regimen for multidrug-resistant tuberculosis: a step in the right direction?
pp. 1137-1138(2)
Author: Lalloo, Umesh G.

Non-communicable diseases, tobacco, and The Union
pp. 1139-1140(2)
Authors: Schraufnagel, Dean E.; Latif, Ehsan

Advances in the management of pulmonary disease due to Mycobacterium abscessus complex
pp. 1141-1148(8)
Authors: Koh, W-J.; Stout, J. E.; Yew, W-W.

Review of policy and status of implementation of collaborative HIV-TB activities in 23 high-burden countries
pp. 1149-1158(10)
Authors: Gupta, S.; Granich, R.; Date, A.; Lepere, P.; Hersh, B.; Gouws, E.; Samb, B.

Cost-effectiveness of the Three I's for HIV/TB and ART to prevent TB among people living with HIV
pp. 1159-1165(7)
Authors: Gupta, S.; Abimbola, T.; Date, A.; Suthar, A. B.; Bennett, R.; Sangrujee, N.; Granich, R.

High prevalence and risk factors associated with latent tuberculous infection in two Colombian prisons
pp. 1166-1171(6)
Authors: Rueda, Z. V.; Arroyave, L.; Marin, D.; López, L.; Keynan, Y.; Giraldo, M. R.; Pulido, H.; Arbeláez, M. P.

Phylogenetic associations with drug-resistant Mycobacterium tuberculosis isolates in a paediatric population
pp. 1172-1179(8)
Authors: Arora, J.; Sidiq, Z.; Sharma, S.; Singhal, R.; Bhalla, M.; Couvin, D.; Sarin, R.; Rastogi, N.; Myneedu, V. P.

Successful ‘9-month Bangladesh regimen’ for multidrug-resistant tuberculosis among over 500 consecutive patients
pp. 1180-1187(8)
Authors: Aung, K. J. M.; Van Deun, A.; Declercq, E.; Sarker, M. R.; Das, P. K.; Hossain, M. A.; Rieder, H. L.

High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses
pp. 1188-1194(7)
Authors: Piubello, A.; Harouna, S. Hassane; Souleymane, M. B.; Boukary, I.; Morou, S.; Daouda, M.; Hanki, Y.; Van Deun, A.

Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes
pp. 1195-1201(7)
Authors: Mor, Z.; Goldblatt, D.; Kaidar-Shwartz, H.; Cedar, N.; Rorman, E.; Chemtob, D.

Trends, seasonality and forecasts of pulmonary tuberculosis in Portugal
pp. 1202-1210(9)
Authors: Bras, A. L.; Gomes, D.; Filipe, P. A.; de Sousa, B.; Nunes, C.

Tuberculosis and risk of cancer: a Danish nationwide cohort study
pp. 1211-1219(9)
Authors: Simonsen, D. F.; Farkas, D. K.; Søgaard, M.; Horsburgh, C. R.; Sørensen, H. T.; Thomsen, R. W.

Tuberculosis in older adults in Soweto, South Africa
pp. 1220-1222(3)
Authors: Karstaedt, A. S.; Bolhaar, M.

Sputum induction for tuberculosis diagnosis in an Arctic setting: a cost comparison
pp. 1223-1230(8)
Authors: Sugarman, J.; Alvarez, G. G.; Schwartzman, K.; Oxlade, O.

Chest radiography for active tuberculosis case finding in the homeless: a systematic review and meta-analysis
pp. 1231-1236(6)
Authors: Paquette, K.; Cheng, M. P.; Kadatz, M. J.; Cook, V. J.; Chen, W.; Johnston, J. C.

Implementation efficiency of a diagnostic algorithm in sputum smear-negative presumptive tuberculosis patients
pp. 1237-1242(6)
Authors: Chadha, V. K.; Praseeja, P.; Hemanthkumar, N. K.; Shivshankara, B. A.; Sharada, M. A.; Nagendra, N.; Padmesh, R.; Puttaswamy, G.; Magesh, V.; Thomas, B.; Kumar, P.

Role of pre-Xpert^® screening using chest X-ray in early diagnosis of smear-negative pulmonary tuberculosis
pp. 1243-1244(2)
Authors: Somashekar, N.; Chadha, V. K.; Praseeja, P.; Sharada, M. A.; Chandrakala, G. R.; Srivastava, R.; Kumar, P.; Japananda, Swami

Monitoring liver function among patients who initiated anti-tuberculosis drugs in Taiwan, 2000–2011
pp. 1245-1251(7)
Authors: Chou, H-C.; Lin, S-W.; Chen, W-W.; Ke, W-M.; Chao, P-H.; Hsiao, F-Y.

Results at 30 months of a randomised trial of FDCs and separate drugs for the treatment of tuberculosis
pp. 1252-1254(3)
Authors: Nunn, A. J.; Cook, S. V.; Burgos, M.; Rigouts, L.; Yorke-Edwards, V.; Anyo, G.; Kim, S-J.; Enarson, D. A.; Jindani, A.; Lienhardt, C.

False-positive rifampicin resistance on Xpert^® MTB/RIF caused by a silent mutation in the rpoB gene
pp. 1255-1257(3)
Authors: Mathys, V.; van de Vyvere, M.; de Droogh, E.; Soetaert, K.; Groenen, G.

BCG vaccination policy in Greece: time for another review?
pp. 1258-1258(1)
Authors: Gabriele, Francesca; Katragkou, Aspasia; Roilides, Emmanuel

Controlling tuberculosis in India: a need to implement an electronic recording and reporting system
pp. 1259-1259(1)
Author: Atre, Sachin

Active tuberculosis screening of close contacts among the urban poor: a Cambodian experience
pp. 1259-1260(2)
Authors: Lorent, N.; Choun, K.; Thai, S.; Rigouts, L.; Lynen, L.